Workflow
CNBC
icon
Search documents
Palantir stock drops 7% on valuation concerns as CEO Karp rips short-seller 'market manipulation'
CNBC· 2025-11-04 15:04
Core Viewpoint - Palantir's stock experienced a 7% decline due to concerns over its high valuation and a short position taken by investor Michael Burry, despite the company reporting strong financial results and raising its full-year guidance [1]. Financial Performance - Palantir reported revenues exceeding $1 billion for the second consecutive quarter, indicating robust financial health [1]. - The company provided stronger-than-expected guidance for the full year, reflecting confidence in its future performance [1]. Market Reaction - The stock's decline overshadowed the positive financial results, highlighting the impact of market sentiment and external factors such as short selling [1]. - Goldman Sachs noted that the muted stock reaction was in the context of high expectations, as Palantir had previously outperformed by 7% in revenue last quarter and had a significant year-to-date performance increase of 175% [2]. Management Commentary - CEO Alex Karp criticized short sellers, labeling their actions as "market manipulation" and defending the company's performance as one of the best in the industry [1].
Metsera says Novo Nordisk's new bid for obesity drugmaker is ‘superior' to revised Pfizer offer
CNBC· 2025-11-04 14:40
Core Viewpoint - Novo Nordisk's new bid for Metsera is considered superior to Pfizer's revised offer, intensifying competition between the two pharmaceutical companies in the obesity biotech sector [1][2]. Group 1: Bid Details - Novo Nordisk's proposal values Metsera at up to $86.20 per share, totaling approximately $10 billion, which represents a 159% premium over Metsera's closing price before Pfizer's initial acquisition announcement [2]. - Pfizer's revised offer values Metsera at up to $70 per share, amounting to around $8.1 billion [2]. Group 2: Legal and Competitive Landscape - Pfizer has filed a second lawsuit against Novo Nordisk and Metsera, claiming that Novo's attempt to outbid Pfizer is anticompetitive [3]. - The competition highlights a changing landscape in the weight loss and diabetes drug market, with Novo Nordisk currently losing market share to Eli Lilly and facing challenges from cheaper alternatives [3][4]. Group 3: Strategic Implications - For Pfizer, acquiring Metsera could provide a crucial opportunity to enter the obesity treatment market, especially after facing difficulties in launching its own obesity products [4]. - Novo Nordisk, while a pioneer in the market, is struggling to maintain investor confidence due to its drug pipeline and increasing competition [4].
Alex Karp blasts 'Big Short' investor Michael Burry as 'bats--- crazy' for bets against Palantir, Nvidia
CNBC· 2025-11-04 14:30
Core Viewpoint - Palantir's CEO Alex Karp criticized short-sellers, particularly Michael Burry, for betting against Palantir and Nvidia, arguing that these companies are performing well in the AI sector [1][3][6] Company Performance - Palantir's shares fell approximately 8% in premarket trading despite beating Wall Street estimates for Q3 and providing positive guidance [2] - The company's stock had increased by 173% year-to-date prior to the recent trading session, with a forward price-earnings ratio of 228 [2] Short-Selling Activity - Michael Burry's hedge fund, Scion Asset Management, disclosed put options valued at about $912 million against Palantir and $187 million against Nvidia as of September 30 [3] - Karp suggested that Burry's short positions might be a strategy to exit his investments without incurring significant losses [4] Market Sentiment - There is growing investor caution regarding high valuations in AI-related stocks, contributing to the decline in Palantir's share price [2] - Karp expressed concerns about potential market manipulation related to short-selling activities, emphasizing the strong performance of Palantir [6]
Instacart rolls out AI tools for grocers, Sprouts will be first to use its Cart Assistant
CNBC· 2025-11-04 14:00
Core Insights - Instacart has launched a suite of artificial intelligence tools aimed at enhancing personalized shopping experiences and improving retail operations for grocers [1][2] - The new AI solutions are part of Instacart's enterprise strategy, which has expanded to support hundreds of digital storefronts [1] Group 1: AI Tools and Features - The AI tools include an AI shopping assistant designed for personalized meal planning, budgeting, and product recommendations for shoppers [2] - The AI shopping assistant, named Cart Assistant, can be utilized on retailers' websites through Instacart's Storefront Pro or integrated into AI-powered shopping carts in-store [3] Group 2: Initial Rollout and Industry Impact - Sprouts Farmers Market and Kroger are the first retailers to implement the Cart Assistant on their websites and apps [3] - The introduction of AI technology is seen as a transformation in shopping experiences, with a focus on making them more personal and intuitive for customers [3]
Behind the wave of white-collar layoffs: Old-school cost cutting, tariffs and, yes, AI
CNBC· 2025-11-04 13:16
Core Insights - Corporate America is experiencing significant white-collar layoffs, with over 60,000 roles eliminated this year, raising concerns about the labor market and potential AI-driven recession [4][8] - Companies like Amazon, UPS, and Target are cutting jobs to streamline operations and adapt to new business models, rather than solely due to AI advancements [4][10] Group 1: Layoff Trends - Major layoffs are occurring across various sectors, with Amazon announcing 14,000 corporate job cuts, marking its largest reduction in history [13] - UPS has eliminated 48,000 roles this year, primarily due to strategic shifts and not directly replacing jobs with AI [20][22] - Target's decision to cut 1,800 jobs, about 8% of its corporate workforce, reflects stagnant revenue and a need to reduce complexity [27][31] Group 2: Economic Context - The layoffs are occurring amid persistent inflation, rising delinquencies, and a high average effective tariff rate, contributing to a challenging economic environment [6][8] - Despite the negative news, the stock market remains buoyed by AI mega-caps, indicating a disconnect between job cuts and market performance [8] Group 3: Company-Specific Strategies - Amazon's layoffs are part of a broader strategy to reduce corporate bloat and invest in AI technology, with capital expenditures expected to reach $125 billion this year [15][17] - UPS is pivoting to higher-margin businesses and reducing its reliance on Amazon, which accounted for nearly 12% of its revenue [18][20] - Target's layoffs are aimed at addressing operational inefficiencies and a workforce that has grown faster than sales, with a focus on accelerating technology [31][32]
Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning Squawk
CNBC· 2025-11-04 12:44
Group 1: Palantir Technologies - Palantir Technologies reported third-quarter earnings that exceeded Wall Street expectations, with a revenue forecast of $1.33 billion for the fourth quarter, surpassing analysts' expectations of $1.19 billion [1][5] - The company's stock initially rose after the earnings report but later fell over 7% in extended trading, despite a 25-fold increase in shares over the past three years and a 170% rise this year [5] - CEO Alex Karp attributed the strong performance to artificial intelligence and addressed critics during the earnings call, while also discussing controversial contracts with U.S. Immigration and Customs Enforcement [5] Group 2: Yum Brands and Pizza Hut - Yum Brands announced it is exploring strategic options for Pizza Hut, indicating a potential sale, as the brand's performance has declined post-pandemic [2][3] - The company reported third-quarter earnings that narrowly beat revenue expectations, reflecting a "K-shaped" economic recovery [4] Group 3: Kimberly-Clark and Kenvue - Kimberly-Clark is acquiring Kenvue in a $48.7 billion deal, which could create a significant player in the consumer staples market [5][6] - Following the announcement, Kimberly-Clark's shares dropped 14%, while Kenvue's shares surged 12% [6] Group 4: Starbucks - Starbucks is forming a joint venture with Boyu Capital to manage its China business, valued at over $13 billion, in a $4 billion deal expected to close in the second quarter of the 2026 fiscal year [11][12] - The China business has faced challenges due to the pandemic and competition, leading to a decrease in average ticket prices and profits [12]
Uber beats third-quarter revenue expectations
CNBC· 2025-11-04 12:16
Dara Khosrowshahi, CEO, Uber Technologies speaks during the third day of the FII PRIORITY Summit held at the Faena Hotel on February 21, 2025 in Miami Beach, Florida.Uber beat Wall Street's third-quarter revenue expectations on Tuesday.Shares fell 4%.Earnings per share: $3.11. It was not immediately clear if that was comparable to the 68 cents expected by LSEG analysts.Revenue: $13.47 billion vs. $13.28 billion expected by LSEG"This was our strongest growth since the end of 2023 and the largest trip volume ...
Yum Brands quarterly revenue rises 8%, fueled by Taco Bell and KFC
CNBC· 2025-11-04 12:00
A Taco Bell logo is displayed outside their restaurant on Feb. 28, 2025 in San Diego, California.Yum Brands on Tuesday reported quarterly earnings and revenue growth, fueled by strong demand for Taco Bell and improved U.S. sales for KFC.The restaurant company also announced plans to review strategic options for Pizza Hut. The embattled pizza chain has struggled to win over diners in recent years. In its home market, pizza fatigue after pandemic lockdowns have led to slumping sales, and rivals like Domino's ...
Pfizer tops estimates, raises profit guidance even as sales fall
CNBC· 2025-11-04 11:56
Core Insights - Pfizer reported third-quarter earnings and revenue that exceeded estimates, raising its full-year profit guidance due to cost-cutting measures offsetting declining sales [1] - The company became the first drugmaker to agree to sell medications at lower prices under a deal with President Trump, linking U.S. drug prices to those abroad [1] - Pfizer plans to invest $70 billion in U.S. manufacturing and research facilities as part of a three-year grace period to avoid pharmaceutical-specific tariffs [2] Financial Performance - Adjusted earnings per share were reported at 87 cents, surpassing the expected 63 cents [4] - Revenue for the quarter was $16.65 billion, slightly above the expected $16.58 billion [4] Competitive Landscape - Pfizer is engaged in a bidding war with Novo Nordisk for the acquisition of obesity biotech Metsera, filing a lawsuit against Novo Nordisk for alleged anticompetitive practices [3]
Yum Brands to review strategic options for Pizza Hut, opening the door to a sale
CNBC· 2025-11-04 11:50
Core Viewpoint - Yum Brands is exploring strategic options for Pizza Hut due to its underperformance and the need for additional actions to realize the brand's full value, which may be better executed outside of Yum [1] Group 1: Strategic Review - The company has not set a deadline for the review process, and potential outcomes may include divestiture, joint venture, or sale of a stake in Pizza Hut [2] - The review aims to address the challenges faced by Pizza Hut and improve its market position [1][2] Group 2: Historical Context - Pizza Hut has been part of Yum Brands alongside KFC and Taco Bell since PepsiCo spun off the restaurants in 1997 [3] - The announcement follows years of struggle for Pizza Hut, which has attempted to reposition itself as a delivery and carryout option [3][4] Group 3: Market Performance - Before the pandemic, Pizza Hut faced challenges in shifting its image from a dine-in venue to a delivery service [4] - Following a surge in sales during the pandemic, the chain has experienced a decline due to "pizza fatigue" as restrictions eased [4] - Pizza Hut's market share in the U.S. pizza market has decreased from 22.6% in 2019 to 18.7% in 2024, losing customers to competitors like Domino's Pizza [5] Group 4: Industry Trends - Other restaurant companies are divesting struggling parts of their businesses to improve balance sheets, indicating a trend in the industry [5][6] - Recent examples include Starbucks selling a majority stake in its China business and Jack in the Box divesting Del Taco for $115 million [6]